Full Text
The Budget Impact of Brodalumab for the Treatment of Moderate-to-Severe Plaque Psoriasis on U.S. Commercial Health Plans

Abstract

Authors

SR Feldman JJ Wu S Rastogi B Menges M Lingohr-Smith J Lin

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×